151 related articles for article (PubMed ID: 34519853)
1. Results of mass screening for neuroblastoma in 18-month-old infants in Osaka area, Japan.
Yamamichi T; Oue T; Irie A; Inoue M; Takama Y; Nomura M; Yoneda A; Okuyama H; Usui N
Pediatr Surg Int; 2021 Dec; 37(12):1645-1649. PubMed ID: 34519853
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
Yokoyama S; Hirakawa H; Ueno S; Yabe H; Hiraoka N
Pediatrics; 1999 May; 103(5):e67. PubMed ID: 10224211
[TBL] [Abstract][Full Text] [Related]
3. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.
Yamamoto K; Hayashi Y; Hanada R; Kikuchi A; Ichikawa M; Tanimura M; Yoshioka S
J Clin Oncol; 1995 Aug; 13(8):2033-8. PubMed ID: 7636545
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
[TBL] [Abstract][Full Text] [Related]
5. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group.
Sawada T; Hirayama M; Nakata T; Takeda T; Takasugi N; Mori T; Maeda K; Koide R; Hanawa Y; Tsunoda A
Lancet; 1984 Aug; 2(8397):271-3. PubMed ID: 6146820
[TBL] [Abstract][Full Text] [Related]
6. Mass screening for neuroblastoma in Miyagi Prefecture.
Itano M; Morita S; Fujie H; Ohashi Y; Minegishi N; Minegishi M; Yamaguchi Y; Sato T; Tsuchiya S; Konno T
Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
[TBL] [Abstract][Full Text] [Related]
7. Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.
Kerbl R; Urban CE; Ladenstein R; Ambros IM; Spuller E; Mutz I; Amann G; Kovar H; Gadner H; Ambros PF
Med Pediatr Oncol; 1997 Jul; 29(1):1-10. PubMed ID: 9142198
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening.
Honjo S; Doran HE; Stiller CA; Ajiki W; Tsukuma H; Oshima A; Coleman MP
Int J Cancer; 2003 Feb; 103(4):538-43. PubMed ID: 12478672
[TBL] [Abstract][Full Text] [Related]
9. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds.
Hayashi Y; Ohi R; Yaoita S; Nakamura M; Kikuchi Y; Konno T; Tsuchiya S; Shiraishi H
J Pediatr Surg; 1995 Mar; 30(3):467-70. PubMed ID: 7760244
[TBL] [Abstract][Full Text] [Related]
10. Mass screening of neuroblastoma in Sapporo City, Japan.
Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
[TBL] [Abstract][Full Text] [Related]
11. Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan.
Ajiki W; Tsukuma H; Oshima A; Kawa K
Cancer Causes Control; 1998 Dec; 9(6):631-6. PubMed ID: 10189049
[TBL] [Abstract][Full Text] [Related]
12. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
Takeda T; Shimada M; Iizuka S; Takasugi N
Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
[TBL] [Abstract][Full Text] [Related]
13. Past and future of neuroblastoma screening in Japan.
Sawada T
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
[TBL] [Abstract][Full Text] [Related]
14. Mass screening for neuroblastoma targeting children age 14 months in Sapporo City: a preliminary report.
Nishi M; Miyake H; Takeda T; Hanai J; Kikuchi Y; Hirama T
Cancer; 1998 May; 82(10):1973-7. PubMed ID: 9587132
[TBL] [Abstract][Full Text] [Related]
15. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
[TBL] [Abstract][Full Text] [Related]
16. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions.
Suita S
J Pediatr Surg; 2002 Jul; 37(7):949-54. PubMed ID: 12077747
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
[TBL] [Abstract][Full Text] [Related]
18. Screening for neuroblastoma: a review of the evidence.
Chamberlain J
J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
[TBL] [Abstract][Full Text] [Related]
19. Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan.
Ioka A; Inoue M; Yoneda A; Nakamura T; Hara J; Hashii Y; Sakata N; Yamato K; Tsukuma H; Kawa K
J Epidemiol; 2016; 26(4):179-84. PubMed ID: 26548355
[TBL] [Abstract][Full Text] [Related]
20. VMA mass screening program of neuroblastoma for infants in Nagoya City, Japan.
Kodama K; Nakata T; Ishii J; Mitani K; Tsunooka H; Masaoka A; Aoyama M
Am J Public Health; 1985 Feb; 75(2):173-5. PubMed ID: 3966625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]